AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27

Authors: Biswas, DK Cruz, A Pettit, N Mutter, GL Pardee, AB
Citation: Dk. Biswas et al., A therapeutic target for hormone-independent estrogen receptor-positive breast cancers, MOL MED, 7(1), 2001, pp. 59-67

Authors: Martin, KJ Graner, E Li, Y Price, LM Kritzman, BM Fournier, MV Rhei, E Pardee, AB
Citation: Kj. Martin et al., High-sensitivity array analysis of gene expression for the early detectionof disseminated breast tumor cells in peripheral blood, P NAS US, 98(5), 2001, pp. 2646-2651

Authors: Geng, Y Yu, QY Whoriskey, W Dick, F Tsai, KY Ford, HL Biswas, DK Pardee, AB Amati, B Jacks, T Richardson, A Dyson, N Sicinski, P
Citation: Y. Geng et al., Expression of cyclins E1 and E2 during mouse development and in neoplasia, P NAS US, 98(23), 2001, pp. 13138-13143

Authors: Biswas, DK Dai, SC Cruz, A Weiser, B Graner, E Pardee, AB
Citation: Dk. Biswas et al., The nuclear factor kappa B (NF-kappa B): A potential therapeutic target for estrogen receptor negative breast cancers, P NAS US, 98(18), 2001, pp. 10386-10391

Authors: Blagosklonny, MV Pardee, AB
Citation: Mv. Blagosklonny et Ab. Pardee, Exploiting cancer cell cycling for selective protection of normal cells, CANCER RES, 61(11), 2001, pp. 4301-4305

Authors: Fournier, MV Martin, KJ Pardee, AB
Citation: Mv. Fournier et al., Solid tumor cancer markers and applications to steroid hormone research, METH MOL B, 176, 2001, pp. 329-340

Authors: Li, YZ Li, CJ Yu, DH Pardee, AB
Citation: Yz. Li et al., Potent induction of apoptosis by beta-lapachone in human multiple myeloma cell lines and patient cells, MOL MED, 6(12), 2000, pp. 1008-1015

Authors: Huang, LL Pardee, AB
Citation: Ll. Huang et Ab. Pardee, Suberoylanilide hydroxamic acid as a potential therapeutic agent for humanbreast cancer treatment, MOL MED, 6(10), 2000, pp. 849-866

Authors: Huang, LL Sowa, Y Sakai, T Pardee, AB
Citation: Ll. Huang et al., Activation of the p21(WAF1/CIP1) promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites, ONCOGENE, 19(50), 2000, pp. 5712-5719

Authors: Biswas, DK Cruz, AP Pardee, AB
Citation: Dk. Biswas et al., Detection of the level of estrogen receptor and functional variants in human breast cancers by novel assays, BIOTECHNIQU, 29(5), 2000, pp. 1056

Authors: Melichar, H Bosch, I Molnar, GM Huang, L Pardee, AB
Citation: H. Melichar et al., Detection of eukaryotic cDNA in differential display is enhanced by the addition of E-coli RNA, BIOTECHNIQU, 28(1), 2000, pp. 76

Authors: Martin, KJ Pardee, AB
Citation: Kj. Martin et Ab. Pardee, Identifying expressed genes, P NAS US, 97(8), 2000, pp. 3789-3791

Authors: Biswas, DK Cruz, AP Gansberger, E Pardee, AB
Citation: Dk. Biswas et al., Epidermal growth factor-induced nuclear factor kappa B activation: A majorpathway of cell-cycle progression in estrogen-receptor negative breast cancer cells, P NAS US, 97(15), 2000, pp. 8542-8547

Authors: Ford, HL Landesman-Bollag, E Dacwag, CS Stukenberg, PT Pardee, AB Seldin, DC
Citation: Hl. Ford et al., Cell cycle-regulated phosphorylation of the human SIX1 homeodomain protein, J BIOL CHEM, 275(29), 2000, pp. 22245-22254

Authors: Martin, K Kritzman, DM Price, LM Koh, B Kwan, CP Zhang, XH Mackay, A O'Hare, MJ Kaelin, DM Mutter, GL Pardee, AB Sager, R
Citation: K. Martin et al., Linking gene expression patterns to therapeutic groups in breast cancer, CANCER RES, 60(8), 2000, pp. 2232-2238

Authors: Guang, RJ Ford, JL Fu, YN Li, YZ Shaw, LM Pardee, AB
Citation: Rj. Guang et al., Drg-1 as a differentiation-related, putative metastatic suppressor gene inhuman colon cancer, CANCER RES, 60(3), 2000, pp. 749-755

Authors: Fournier, MV Carvalho, MD Pardee, AB
Citation: Mv. Fournier et al., A strategy to identify genes associated with circulating solid tumor cell survival in peripheral blood, MOL MED, 5(5), 1999, pp. 313-319

Authors: Li, YZ Li, CJ Pinto, AV Pardee, AB
Citation: Yz. Li et al., Release of mitochondrial cytochrome C in both apoptosis and necrosis induced by beta-lapachone in human carcinoma cells, MOL MED, 5(4), 1999, pp. 232-239

Authors: Huang, LL Pardee, AB
Citation: Ll. Huang et Ab. Pardee, beta-lapachone induces cell cycle arrest and apoptosis in human colon cancer cells, MOL MED, 5(11), 1999, pp. 711-720

Authors: Ford, HL Pardee, AB
Citation: Hl. Ford et Ab. Pardee, Cancer and the cell cycle, J CELL BIOC, 1999, pp. 166-172

Authors: Martin, KJ Pardee, AB
Citation: Kj. Martin et Ab. Pardee, Principles of differential display, METH ENZYM, 303, 1999, pp. 234-258

Authors: Li, CJ Li, YZ Pinto, AV Pardee, AB
Citation: Cj. Li et al., Potent inhibition of tumor survival in vivo by beta-lapachone plus taxol: Combining drugs imposes different artificial checkpoints, P NAS US, 96(23), 1999, pp. 13369-13374

Authors: Cohen, SS Li, C Ding, LN Cao, YZ Pardee, AB Shevach, EM Cohen, DI
Citation: Ss. Cohen et al., Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge, P NAS US, 96(19), 1999, pp. 10842-10847

Authors: Guan, RJ Fu, YN Holt, PR Pardee, AB
Citation: Rj. Guan et al., Association of K-ras mutations with p16 methylation in human colon cancer, GASTROENTY, 116(5), 1999, pp. 1063-1071

Authors: Fournier, MV Guimaraes, FC Paschoal, MEM Ronco, LV Carvalho, MDC Pardee, AB
Citation: Mv. Fournier et al., Identification of a gene encoding a human oxysterol-binding protein-homologue: A potential general molecular marker for blood dissemination of solid tumors, CANCER RES, 59(15), 1999, pp. 3748-3753
Risultati: 1-25 | 26-27